PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 2.92M (Avg.)
-0.48 | -4.19
These metrics indicate whether the stock trades cheaply or expensively relative to its fundamentals. Value investors use them to find mispricings—buying stocks that appear undervalued, with solid long-term prospects and limited downside risk.
68.12
Positive P/E while Healthcare median is negative at -2.89. Peter Lynch would investigate competitive advantages in a distressed Healthcare.
669.56
P/S exceeding 1.5x Healthcare median of 13.12. Jim Chanos would check for potential multiple compression risks.
14.11
P/B exceeding 1.5x Healthcare median of 3.38. Jim Chanos would check for potential asset write-down risks.
-148.99
Negative FCF while Healthcare median P/FCF is -14.33. Seth Klarman would investigate cash flow improvement potential.
-1078.09
Negative operating cash flow while Healthcare median P/OCF is -9.72. Seth Klarman would investigate operational improvement potential.
14.11
Fair value ratio exceeding 1.5x Healthcare median of 3.42. Jim Chanos would check for valuation bubble risks.
0.37%
Positive earnings while Healthcare median shows losses. Peter Lynch would examine earnings quality advantage.
-0.67%
Negative FCF while Healthcare median yield is -0.50%. Seth Klarman would investigate cash flow improvement potential.